Atlas Trials

Safety and Efficacy of Treg Cell in the Treatment of GVHD

Clinical trial NCT06411184 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06411184
Sponsor
Xuzhou Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
GVHD
Start date
2024-06-01
Primary completion
2025-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.